Yoo receives grant from Hereditary Disease Foundation

Andrew Yoo, PhD, a professor of developmental biology at WashU Medicine, has received the 2024 Transformative Research Award, a two-year $1 million grant from the Hereditary Disease Foundation. Yoo and his collaborator, Osama Al Dalahmah, MD, PhD, of Columbia University, will use this support to pursue potential therapeutics for Huntington’s disease, an inherited neurodegenerative disorder […]

Zhao, Musiek receive NIH grant to study neurodegenerative diseases

Guoyan Zhao, PhD, an assistant professor of genetics and of neurology, and Erik Musiek, MD, PhD, the Charlotte & Paul Hagemann Professor of Neurology, both of WashU Medicine, have received a $433,000 grant from the National Institute on Aging of the National Institutes of Health (NIH) to study brain cells called astrocytes and their roles […]

Board grants faculty tenure

At the Washington University in St. Louis Board of Trustees meeting Sept. 27, numerous faculty members were granted tenure, effective that day. Granting of tenure Kirsten Gilbert Alberts, PhD as an associate professor of psychiatry at WashU Medicine; Robert A. Campbell, PhD as an associate professor of emergency medicine at WashU Medicine; Carmen M. Halabi, MD, PhD as […]

Pappu named American Physical Society fellow

Rohit V. Pappu, PhD, the Gene K. Beare Distinguished Professor of Biomedical Engineering and director of the Center for Biomolecular Condensates at Washington University in St. Louis, has been selected as an American Physical Society Fellow. Pappu was selected for his innovative and fundamental studies regarding intrinsically disordered proteins and phase transitioning behaviors using polymer […]

Link between childhood adverse events, Alzheimer’s disease to be studied

Brian A. Gordon, PhD, an assistant professor of radiology at Washington University School of Medicine in St. Louis and a principal investigator in the Mallinckrodt Institute of Radiology (MIR)’s Neuroimaging Labs Research Center, was selected for the 2024 New Investigator Award from the National Alzheimer’s Coordinating Center and the Alzheimer’s Association. This award is given […]

The brain has a waste removal system and scientists are figuring out how it works

The brain needs to flush out waste products to stay healthy and fend off conditions like Alzheimer’s disease. Scientists are beginning to understand how the the brain’s waste removal system works. [Transcript] A MARTÍNEZ, HOST: Turns out the brain needs regular cleaning. Otherwise, it gets clogged up with waste products, including some associated with diseases […]

Gut bacteria boost immune response to fight tumors

Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. Such an approach to beating cancer has seen significant success in lung cancer and melanoma, among others. Optimistic about its potential, researchers are exploring strategies to improve immunotherapy for cancers that don’t respond well to […]

Some brain tumors may be linked to head injury, mouse study suggests

A study in mice by researchers at the School of Medicine indicates that brain injury can lead to brain tumors in susceptible individuals. For this study, they used mice that model people with neurofibromatosis type 1 (NF1), a genetic disorder that causes brain tumors. The study showed that molecules released by injured neurons set off […]

Diwan named inaugural Shaeffer professor

Abhinav Diwan, MD, a highly regarded cardiologist with expertise in the molecular underpinnings of cardiovascular disease, has been named the inaugural Charlie W. Shaeffer, MD, Professor of Cardiology at Washington University School of Medicine in St. Louis. Diwan was installed by David H. Perlmutter, MD, executive vice chancellor for medical affairs, the George and Carol […]

Immunotherapy for Alzheimer’s disease shows promise in mouse study

Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer’s drugs — the first proven to change the course of the disease — work by tagging amyloid for […]

WashU engineers manage a first: measuring pH in cell condensates

Scientists trying to understand the physical and chemical properties that govern biomolecular condensates now have a crucial way to measure pH and other emergent properties of these enigmatic, albeit important cellular compartments. Condensates are communities of proteins and nucleic acids. They lack a membrane and come together and fall apart as needed. The nucleolus is […]

Three named 2023 Young Investigator grantees

Sarah D. Ackerman, PhD, Gabor Egervari, MD, PhD and Tao Xie, PhD, all of Washington University School of Medicine in St. Louis, have been named 2023 Young Investigator grantees by the Brain & Behavior Research Foundation. This year’s funding will support 150 promising early-career scientists across the field of neuropsychiatry with innovative ideas in mental health research. The two-year grant […]

Pappu installed as Gene K. Beare Distinguished Professor of Biomedical Engineering

Rohit V. Pappu, PhD, an internationally renowned researcher in biomolecular condensates and intrinsically disordered proteins, was installed Oct. 9 as the Gene K. Beare Distinguished Professor of Biomedical Engineering at Washington University in St. Louis. Pappu is a professor of biomedical engineering and director of the Center for Biomolecular Condensates at the McKelvey School of […]

NIH funds study of ultrasound with genetics to treat brain disorders

Researchers have developed methods to study and manipulate areas of the brain, though many of those methods are restricted by the limited depth that light can reach within the brain. A multidisciplinary team at Washington University in St. Louis plans to overcome that limitation by integrating ultrasound with genetics to precisely modify neurons in the […]

Tau-based biomarker tracks Alzheimer’s progression

Two pathologies drive the progression of Alzheimer’s disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines. Tracking the course of the disease in individual patients has been challenging because there’s been no easy way to measure […]

Air monitor can detect COVID-19 virus variants in about 5 minutes

Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive biosensing technique, researchers at Washington University in St. Louis have created a real-time monitor that can detect any of […]

Altered gut bacteria may be early sign of Alzheimer’s disease

People in the earliest stage of Alzheimer’s disease — after brain changes have begun but before cognitive symptoms become apparent — harbor an assortment of bacteria in their intestines that differs from the gut bacteria of healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis. The findings, […]

Induction of a torpor-like state with ultrasound

Some mammals and birds have a clever way to preserve energy and heat by going into torpor, during which their body temperature and metabolic rate drop to allow them to survive potentially fatal conditions in the environment, such as extreme cold or lack of food. While a similar condition was proposed for scientists making flights […]

Pappu to explore ways in which charge contributes to diverse states of proteins

Intrinsically disordered proteins (IDPs) are defined by structural diversity, and the determinants of this diversity are an important area of biophysical investigation. IDPs are involved in a range of important biological processes, including cell signaling and regulation, that allow healthy cells to respond to environmental factors appropriately, but they are also associated with human diseases […]

Drug for rare form of ALS, based in part on WashU research, approved by FDA

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS), a paralyzing neurological disease. Known as tofersen, the drug has been shown to slow progression of the deadly disease. International clinical trials of tofersen, developed by the global biotechnology company Biogen Inc., […]